期刊文献+

熊去氧胆酸联合苯扎贝特治疗难治性原发性胆汁性肝硬化的效果 被引量:2

下载PDF
导出
摘要 目的观察熊去氧胆酸联合苯扎贝特治疗难治性原发性胆汁性肝硬化的效果及对免疫功能的影响。方法将该院50例难治性原发性胆汁性肝硬化患者,按软件随机码分为观察组与对照组,各25例。观察组予熊去氧胆酸联合苯扎贝特,对照组予熊去氧胆酸,治疗3个月,观察效果。结果治疗后各症状积分,血清TBi L、AST、ALT、GGT均有明显下降,观察组低于对照组;两组C D_4^+水平下降,CD_8^+水平升高,但观察组这种变化更明显,除TBIL外组间差异均有统计学意义。结论熊去氧胆酸联合苯扎贝特治疗原发性胆汁性肝硬化疗效确切,可调节患者免疫状态紊乱。
作者 李爱民
出处 《中国乡村医药》 2016年第12期27-28,共2页
  • 相关文献

参考文献4

  • 1王立,孔芳,张婷,马丹旭,张烜,徐东,李永哲,张奉春.难治性原发性胆汁性肝硬化患者的免疫学随诊[J].中华风湿病学杂志,2013,17(2):86-90. 被引量:3
  • 2Park YW,Kee SJ,Cho YN,et al. ImPaired differentiationand cytotoxicity of natural killer cells in systemic lupuserythematosus[J]. Arthritis Rheum,2009,60(6):1753.
  • 3Corpeehot C,Abenavoli L,Rabahi N,et a1. Biochemicalresponse to ursodeoxycholic acid and long-term prognosisin primary bil iary cirrhosis[J]. Hepatology,2008,48(3):871.
  • 4Honda A,Ikegami T,Nakamuta M,et a1. Anticholestaticeffects of bezafibrate in patients with primary biliary cirrhosistreated with ursodeoxycholic acid[J]. Hepatology,2013,57(5):1931.

二级参考文献12

  • 1Corpechot C,Abenacoli L,Rabahi N. Biochemical respoase to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis[J].Hepatology,2008.871-877.
  • 2Poupon R. Primary biliary cirrhosis:a 2010 update[J].Journal of Hepatology,2010.745-758.
  • 3Lindor KD,Gershwin ME,Poupon R. Primary biliary cirrhosis[J].Hepatology,2009,(1):291-308.doi:10.1002/hep.22906.
  • 4Nishimoto N,Hashimoto J,Miyasaka N. Study of active controlled monotherapy used for rheumatoid arthritis,an IL-6 inhibitor (SAMURAI):evidence of clinical and radiographic benefit from an X-ray reader-blinded randomized controlled trial of tocilizumab[J].Annals of the Rheumatic Diseases,2007.1162-1167.
  • 5Zhou L,Lopes JE,Chong MM. TGF-beta-induced Foxp3 inhibits Th17 cell differentiation by antagonizing ROR gamma function[J].Nature,2008.236-240.
  • 6Schwartz RE,Reyes M,Koodie L. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells[J].Journal of Clinical Investigation,2002.1291-1302.
  • 7Li Z,Mizuno S,Nakamura T. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases[J].American Journal of Physiology-Gastrointestinal and Liver Physiology,2007.639-646.
  • 8Avital I,Inderbitzin D,Aoki T. Isolation,characterization,and transplantation of bone marrow-derived hepatocyte stem cells[J].Biochemical and Biophysical Research Communications,2001.156-164.
  • 9Sasaki M,Ikeda H,Kataoka H. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis[J].VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2006.462-471.
  • 10李洁,高丽霞,张奉春.原发性胆汁性肝硬化停用熊去氧胆酸治疗的前瞻性研究[J].中华风湿病学杂志,2009,13(8):525-527. 被引量:7

共引文献2

同被引文献25

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部